Skip to main content

Status Epilepticus News

Guidelines Updated by National Association of Epilepsy Centers

FRIDAY, Feb. 9, 2024 – Updated evidence-based guidelines have been developed by the National Association of Epilepsy Centers and published online Feb. 2 in Neurology. Fred A. Lado, M.D., Ph.D., from...

Could You Recognize the More Subtle Signs of a Seizure?

THURSDAY, Nov. 2, 2023 – A seizure doesn’t always look like what you see in the movies, but a new survey finds most Americans don't know what the more subtle signs of seizures are. “Anything that int...

Experimental Drug XEN1101 Could Rein in Epilepsy Seizures

TUESDAY, Oct. 10, 2023 – For people with tough-to-treat epilepsy, seizures can be both frightening and dangerous, but a new experimental pill may bring significant relief to over one-third of them....

FDA Approves Sesquient (fosphenytoin sodium) for the Treatment of Status Epilepticus in Adult and Pediatric Patients

PAOLI, Pa., — (BUSINESS WIRE) — November 9, 2020 – Sedor Pharmaceuticals, LLC (Sedor) today announced that the U.S. Food and Drug Administration (FDA) has approved Sesquient (fosphenytoin sodium for i...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Epilepsy

Related drug support groups

Valium, Ativan, lorazepam, diazepam